GlassScriptPhysician profile
David C Karpik
NPI 1417966011
$6,870.93
in general payments reported to CMS, 2019-2025
22 companies · $488 in 2025
The $488 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $686 · 2020: $19.40 · 2021: $443 · 2022: $3,072 · 2023: $1,207 · 2024: $955 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,366 · Entertainment: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,365.71 |
| Entertainment | $284.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,187.38 | 2019-2025 | Dailies Total1, Dailies, Total30 |
| Coopervision INC. | $949.87 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $453.96 | 2023-2025 | Infuse, Miebo, Vyzulta |
| Optos, INC. | $359.16 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Dompe US, INC. | $300.87 | 2023-2024 | Oxervate |
| Sun Pharmaceutical Industries INC. | $258.99 | 2021-2025 | Cequa |
| Oyster Point Pharma, INC. | $177.21 | 2023-2024 | Tyrvaya, Ryzumvi |
| Lkc Technologies, INC. | $159.29 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $148.90 | 2019 | |
| Lumibird Medical INC. | $136.63 | 2021 | |
| Maculogix, INC. | $135.36 | 2019 | |
| Shire North American Group INC | $121.42 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $118.56 | 2022 | |
| Lumenis Be INC | $117.05 | 2022 | |
| Abbvie INC. | $72.88 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $48.94 | 2022-2023 | Tearcare System |
| Mallinckrodt Hospital Products INC. | $26.44 | 2025 | Acthar |
| Johnson & Johnson Surgical Vision, INC. | $22.51 | 2022 | |
| Abb Con-Cise Optical Group LLC | $20.72 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Quidel Corporation | $18.18 | 2022 | |
| Biotissue Holdings INC. | $17.21 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Karpik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.